Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
biotech
clinical trials
life sciences
national blog main
alexion pharmaceuticals
alnylam
alnylam pharmaceutials
arena pharmaceuticals
arrowhead pharmaceuticals
artie suckow
boehringer ingelheim
boston
boston blog main
boston top stories
deals
dicerna pharmaceuticals
drug delivery
dtx pharma
eli lilly
financing
hepatitis b
indiana blog main
indiana top stories
jeff friedman
john grundy
johnson & johnson
national top stories
neurodegenerative diseases
primary hyperoxaluria
rna
rna interference
san diego
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
startups
tim scott
vc
wisconsin blog main
What
pharma
3
×
small
3
×
drugs
medicines
rna
way
abandoning
advance
ago
analysed
baggage
benefits
big
biologics
broken
companies
considered
cuts
deal
deliver
design
designed
development
dicerna
diseases
dlc
dtx
evil
exaggerate
favour
flawed
free
gets
hitting
hopelessly
interference
isn't
long
malpractice
manufacture
Language
unset
Current search:
pharma
×
small
×
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@eurogamer.net
7 years ago
Even with the Marketing and Malpractice DLC, Big Pharma just isn't evil enough